20 February 202419 February 2024 Paptic successfully closed the 2023 growth financing round; EUR 27.5 million was raised to accelerate global growth and ability to serve global customers The company’s unique contract manufacturing business model enables rapid capacity increase, and the new financing will also speed up the industrial scale-up of Paptic’s foam-based manufacturing technology
3 November 20162 November 2016 3F Bio voted best speech and MetGen won the John Sime award at Efib 2016 Companies were acknowledged as industrial biotech leaders at this year’s European Forum on Industrial Biotechnology and the Bioeconomy
12 June 2013 2013 BIO World Congress to Feature Focus on Investment Opportunities in Clean Tech Innovative Industrial Biotech Companies to Present to Investors
